| Code | Display |
| A | ALIMENTARY TRACT AND METABOLISM |
| A01 | STOMATOLOGICAL PREPARATIONS |
| A01A | STOMATOLOGICAL PREPARATIONS |
| A01AA | Caries prophylactic agents |
| A01AA01 | sodium fluoride |
| A01AA02 | sodium monofluorophosphate |
| A01AA03 | olaflur |
| A01AA04 | stannous fluoride |
| A01AA30 | combinations |
| A01AA51 | sodium fluoride, combinations |
| A01AB | Antiinfectives and antiseptics for local oral treatment |
| A01AB02 | hydrogen peroxide |
| A01AB03 | chlorhexidine |
| A01AB04 | amphotericin B |
| A01AB05 | polynoxylin |
| A01AB06 | domiphen |
| A01AB07 | oxyquinoline |
| A01AB08 | neomycin |
| A01AB09 | miconazole |
| A01AB10 | natamycin |
| A01AB11 | various |
| A01AB12 | hexetidine |
| A01AB13 | tetracycline |
| A01AB14 | benzoxonium chloride |
| A01AB15 | tibezonium iodide |
| A01AB16 | mepartricin |
| A01AB17 | metronidazole |
| A01AB18 | clotrimazole |
| A01AB19 | sodium perborate |
| A01AB21 | chlortetracycline |
| A01AB22 | doxycycline |
| A01AB23 | minocycline |
| A01AC | Corticosteroids for local oral treatment |
| A01AC01 | triamcinolone |
| A01AC02 | dexamethasone |
| A01AC03 | hydrocortisone |
| A01AC54 | prednisolone, combinations |
| A01AD | Other agents for local oral treatment |
| A01AD01 | epinephrine |
| A01AD02 | benzydamine |
| A01AD05 | acetylsalicylic acid |
| A01AD06 | adrenalone |
| A01AD07 | amlexanox |
| A01AD08 | becaplermin |
| A01AD11 | various |
| A02 | DRUGS FOR ACID RELATED DISORDERS |
| A02A | ANTACIDS |
| A02AA | Magnesium compounds |
| A02AA01 | magnesium carbonate |
| A02AA02 | magnesium oxide |
| A02AA03 | magnesium peroxide |
| A02AA04 | magnesium hydroxide |
| A02AA05 | magnesium silicate |
| A02AA10 | combinations |
| A02AB | Aluminium compounds |
| A02AB01 | aluminium hydroxide |
| A02AB02 | algeldrate |
| A02AB03 | aluminium phosphate |
| A02AB04 | dihydroxialumini sodium carbonate |
| A02AB05 | aluminium acetoacetate |
| A02AB06 | aloglutamol |
| A02AB07 | aluminium glycinate |
| A02AB10 | combinations |
| A02AC | Calcium compounds |
| A02AC01 | calcium carbonate |
| A02AC02 | calcium silicate |
| A02AC10 | combinations |
| A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds |
| A02AD01 | ordinary salt combinations |
| A02AD02 | magaldrate |
| A02AD03 | almagate |
| A02AD04 | hydrotalcite |
| A02AD05 | almasilate |
| A02AF | Antacids with antiflatulents |
| A02AF01 | magaldrate and antiflatulents |
| A02AF02 | ordinary salt combinations and antiflatulents |
| A02AG | Antacids with antispasmodics |
| A02AH | Antacids with sodium bicarbonate |
| A02AX | Antacids, other combinations |
| A02B | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) |
| A02BA | H2-receptor antagonists |
| A02BA01 | cimetidine |
| A02BA02 | ranitidine |
| A02BA03 | famotidine |
| A02BA04 | nizatidine |
| A02BA05 | niperotidine |
| A02BA06 | roxatidine |
| A02BA07 | ranitidine bismuth citrate |
| A02BA08 | lafutidine |
| A02BA51 | cimetidine, combinations |
| A02BA53 | famotidine, combinations |
| A02BB | Prostaglandins |
| A02BB01 | misoprostol |
| A02BB02 | enprostil |
| A02BC | Proton pump inhibitors |
| A02BC01 | omeprazole |
| A02BC02 | pantoprazole |
| A02BC03 | lansoprazole |
| A02BC04 | rabeprazole |
| A02BC05 | esomeprazole |
| A02BC06 | dexlansoprazole |
| A02BC07 | dexrabeprazole |
| A02BC53 | lansoprazole, combinations |
| A02BC54 | rabeprazole, combinations |
| A02BD | Combinations for eradication of Helicobacter pylori |
| A02BD01 | omeprazole, amoxicillin and metronidazole |
| A02BD02 | lansoprazole, tetracycline and metronidazole |
| A02BD03 | lansoprazole, amoxicillin and metronidazole |
| A02BD04 | pantoprazole, amoxicillin and clarithromycin |
| A02BD05 | omeprazole, amoxicillin and clarithromycin |
| A02BD06 | esomeprazole, amoxicillin and clarithromycin |
| A02BD07 | lansoprazole, amoxicillin and clarithromycin |
| A02BD08 | bismuth subcitrate, tetracycline and metronidazole |
| A02BD09 | lansoprazole, clarithromycin and tinidazole |
| A02BD10 | lansoprazole, amoxicillin and levofloxacin |
| A02BD11 | pantoprazole, amoxicillin, clarithromycin and metronidazole |
| A02BX | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) |
| A02BX01 | carbenoxolone |
| A02BX02 | sucralfate |
| A02BX03 | pirenzepine |
| A02BX04 | methiosulfonium chloride |
| A02BX05 | bismuth subcitrate |
| A02BX06 | proglumide |
| A02BX07 | gefarnate |
| A02BX08 | sulglicotide |
| A02BX09 | acetoxolone |
| A02BX10 | zolimidine |
| A02BX11 | troxipide |
| A02BX12 | bismuth subnitrate |
| A02BX13 | alginic acid |
| A02BX51 | carbenoxolone, combinations excl. psycholeptics |
| A02BX71 | carbenoxolone, combinations with psycholeptics |
| A02BX77 | gefarnate, combinations with psycholeptics |
| A02X | OTHER DRUGS FOR ACID RELATED DISORDERS |
| A03 | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| A03A | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| A03AA | Synthetic anticholinergics, esters with tertiary amino group |
| A03AA01 | oxyphencyclimine |
| A03AA03 | camylofin |
| A03AA04 | mebeverine |
| A03AA05 | trimebutine |
| A03AA06 | rociverine |
| A03AA07 | dicycloverine |
| A03AA08 | dihexyverine |
| A03AA09 | difemerine |
| A03AA30 | piperidolate |
| A03AB | Synthetic anticholinergics, quaternary ammonium compounds |
| A03AB01 | benzilone |
| A03AB02 | glycopyrronium bromide |
| A03AB03 | oxyphenonium |
| A03AB04 | penthienate |
| A03AB05 | propantheline |
| A03AB06 | otilonium bromide |
| A03AB07 | methantheline |
| A03AB08 | tridihexethyl |
| A03AB09 | isopropamide |
| A03AB10 | hexocyclium |
| A03AB11 | poldine |
| A03AB12 | mepenzolate |
| A03AB13 | bevonium |
| A03AB14 | pipenzolate |
| A03AB15 | diphemanil |
| A03AB16 | (2-benzhydryloxyethyl)diethyl-methylammonium iodide |
| A03AB17 | tiemonium iodide |
| A03AB18 | prifinium bromide |
| A03AB19 | timepidium bromide |
| A03AB21 | fenpiverinium |
| A03AB53 | oxyphenonium, combinations |
| A03AC | Synthetic antispasmodics, amides with tertiary amines |
| A03AC02 | dimethylaminopropionylphenothiazine |
| A03AC04 | nicofetamide |
| A03AC05 | tiropramide |
| A03AD | Papaverine and derivatives |
| A03AD01 | papaverine |
| A03AD02 | drotaverine |
| A03AD30 | moxaverine |
| A03AE | Serotonin receptor antagonists |
| A03AE01 | alosetron |
| A03AE03 | cilansetron |
| A03AX | Other drugs for functional gastrointestinal disorders |
| A03AX01 | fenpiprane |
| A03AX02 | diisopromine |
| A03AX03 | chlorbenzoxamine |
| A03AX04 | pinaverium |
| A03AX05 | fenoverine |
| A03AX06 | idanpramine |
| A03AX07 | proxazole |
| A03AX08 | alverine |
| A03AX09 | trepibutone |
| A03AX10 | isometheptene |
| A03AX11 | caroverine |
| A03AX12 | phloroglucinol |
| A03AX13 | silicones |
| A03AX14 | valethamate |
| A03AX30 | trimethyldiphenylpropylamine |
| A03AX58 | alverine, combinations |
| A03B | BELLADONNA AND DERIVATIVES, PLAIN |
| A03BA | Belladonna alkaloids, tertiary amines |
| A03BA01 | atropine |
| A03BA03 | hyoscyamine |
| A03BA04 | belladonna total alkaloids |
| A03BB | Belladonna alkaloids, semisynthetic, quaternary ammonium compounds |
| A03BB01 | butylscopolamine |
| A03BB02 | methylatropine |
| A03BB03 | methylscopolamine |
| A03BB04 | fentonium |
| A03BB05 | cimetropium bromide |
| A03C | ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS |
| A03CA | Synthetic anticholinergic agents in combination with psycholeptics |
| A03CA01 | isopropamide and psycholeptics |
| A03CA02 | clidinium and psycholeptics |
| A03CA03 | oxyphencyclimine and psycholeptics |
| A03CA04 | otilonium bromide and psycholeptics |
| A03CA05 | glycopyrronium bromide and psycholeptics |
| A03CA06 | bevonium and psycholeptics |
| A03CA07 | ambutonium and psycholeptics |
| A03CA08 | diphemanil and psycholeptics |
| A03CA09 | pipenzolate and psycholeptics |
| A03CA30 | emepronium and psycholeptics |
| A03CA34 | propantheline and psycholeptics |
| A03CB | Belladonna and derivatives in combination with psycholeptics |
| A03CB01 | methylscopolamine and psycholeptics |
| A03CB02 | belladonna total alkaloids and psycholeptics |
| A03CB03 | atropine and psycholeptics |
| A03CB04 | methylhomatropine and psycholeptics |
| A03CB31 | hyoscyamine and psycholeptics |
| A03CC | Other antispasmodics in combination with psycholeptics |
| A03D | ANTISPASMODICS IN COMBINATION WITH ANALGESICS |
| A03DA | Synthetic anticholinergic agents in combination with analgesics |
| A03DA01 | tropenzilone and analgesics |
| A03DA02 | pitofenone and analgesics |
| A03DA03 | bevonium and analgesics |
| A03DA04 | ciclonium and analgesics |
| A03DA05 | camylofin and analgesics |
| A03DA06 | trospium and analgesics |
| A03DA07 | tiemonium iodide and analgesics |
| A03DB | Belladonna and derivatives in combination with analgesics |
| A03DB04 | butylscopolamine and analgesics |
| A03DC | Other antispasmodics in combination with analgesics |
| A03E | ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS |
| A03EA | Antispasmodics, psycholeptics and analgesics in combination |
| A03ED | Antispasmodics in combination with other drugs |
| A03F | PROPULSIVES |
| A03FA | Propulsives |
| A03FA01 | metoclopramide |
| A03FA02 | cisapride |
| A03FA03 | domperidone |
| A03FA04 | bromopride |
| A03FA05 | alizapride |
| A03FA06 | clebopride |
| A03FA07 | itopride |
| A04 | ANTIEMETICS AND ANTINAUSEANTS |
| A04A | ANTIEMETICS AND ANTINAUSEANTS |
| A04AA | Serotonin (5HT3) antagonists |
| A04AA01 | ondansetron |
| A04AA02 | granisetron |
| A04AA03 | tropisetron |
| A04AA04 | dolasetron |
| A04AA05 | palonosetron |
| A04AA55 | palonosetron, combinations |
| A04AD | Other antiemetics |
| A04AD01 | scopolamine |
| A04AD02 | cerium oxalate |
| A04AD04 | chlorobutanol |
| A04AD05 | metopimazine |
| A04AD10 | dronabinol |
| A04AD11 | nabilone |
| A04AD12 | aprepitant |
| A04AD13 | casopitant |
| A04AD51 | scopolamine, combinations |
| A04AD54 | chlorobutanol, combinations |
| L02BG03 | anastrozole |
| G02CX04 | Cimicifugae rhizoma |
| J07CA02 | diphtheria-pertussis-poliomyelitis-tetanus |
| C10AA01 | simvastatin |